News Minimalist logo

Malaria cases rose, Africa hit hardest, vaccines show promise

The Hindu — April 25, 2024, 10:00 AM UTC

Summary: Malaria cases rose to 249 million in 2022, with Africa bearing 94% of cases and 95% of deaths globally. The RTS,S vaccine, targeting children under 5, prevented 30% from severe malaria. R21/Matrix M, with 75% efficacy, is cost-effective at $2-$4 per dose. Rollout challenges include high demand and limited production. Both vaccines are crucial tools alongside other malaria control strategies.

Full article

Article metrics
Significance5.8
Scale9.0
Magnitude8.0
Potential7.5
Novelty4.0
Actionability5.0
Immediacy7.0
Positivity6.0
Credibility9.0

Timeline:

  1. [5.2]
    African countries roll out malaria vaccine, new baby treatment (Health Policy Watch)
    19d
    Source
  2. [4.8]
    Benin, Liberia, Sierra Leone launch malaria vaccine programs in Africa (Voice of America - VOA News)
    23d
    Source
  3. [5.0]
    New malaria vaccines developed; R21 targets sporozoites, aids control (AllAfrica - Top Africa News)
    24d
    Source
  4. [6.6]
    New malaria vaccines R21 and RTS,S show promise (The Conversation)
    25d

    ScoresSource
  5. [6.7]
    Malaria vaccines show promise in Africa's fight against disease (The Conversation)
    27d

    ScoresSource